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ABSTRACT
Background. Traditional Chinese medicine encompasses a well established
alternate system of medicine based on a broad range of herbal formulations and is
practiced extensively in the region for the treatment of a wide variety of diseases. In
recent years, several reports describe in depth studies of the molecular ingredients
of traditional Chinese medicines on the biological activities including anti-bacterial
activities. The availability of a well-curated dataset of molecular ingredients of tra-
ditional Chinese medicines and accurate in-silico cheminformatics models for data
mining for antitubercular agents and computational filters to prioritize molecules
haspromptedustosearchforpotentialhitsfromthesedatasets.
Results. We used a consensus approach to predict molecules with potential antitu-
bercularactivitiesfromalargedatasetofmolecularingredientsoftraditionalChinese
medicinesavailableinthepublicdomain.Wefurtherprioritized160moleculesbased
on five computational filters (SMARTSfilter) so as to avoid potentially undesirable
molecules. We further examined the molecules for permeability across Mycobacte-
rial cell wall and for potential activities against non-replicating and drug tolerant
Mycobacteria. Additional in-depth literature surveys for the reported antitubercular
activitiesofthemolecularingredientsandtheirsourceswereconsideredfordrawing
supporttoprioritization.
Conclusions. Our analysis suggests that datasets of molecular ingredients of tradi-
tional Chinese medicines offer a new opportunity to mine for potential biological
activities. In this report, we suggest a proof-of-concept methodology to prioritize
molecules for further experimental assays using a variety of computational tools.
We also additionally suggest that a subset of prioritized molecules could be used
for evaluation for tuberculosis due to their additional effect against non-replicating
tuberculosisaswellastheadditionalhepato-protectionofferedbythesourceofthese
ingredients.
Subjects Bioinformatics, Drugs and Devices, Pharmacology, Computational Science
Keywords Tuberculosis, Traditional Chinese medicine, Cheminformatics, Virtual screening,
Data-mining
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Traditional medicine still forms the mainstay of healthcare in many parts of the world.
Traditional Chinese medicine (TCM) is one of the well developed and established systems
of traditional medicine, and largely followed in some parts of Eastern Asia where it forms
oneofthemajoralternativemedicinalpractices(Ooi,1993).TCMasasystemofmedicine
was, founded almost 2,000 years ago and is dependent on the concepts of five elements
and guided by the Chinese philosophy of Ying and Yang (Qiu, 2007; Normile, 2003).
Recently, efforts have been underway to investigate the practice of TCM using molecular
approaches.Thishasledtotheidentificationandmolecularcharacterizationofingredients
used in traditional Chinese medicines (Wang, Hao & Chen, 2007; Sucher, 2006). These
efforts have led to the systematic curation of the molecular structures and the biological
activities of ingredients of traditional Chinese medicines (Chen et al., 2006; Fang et al.,
2008; Chen, 2011; Zhou, Xie & Yan, 2011). In addition, molecular basis of the action and
mechanismsofmodulation(Li&Brown,2009;Wenetal.,2011),immunomodulatoryand
antimicrobial activities of traditional Chinese medicines have also been actively pursued
(Nair&Abraham,2008;Naderetal.,2010).
Tuberculosis is considered one of the major tropical diseases caused by intracellular
pathogen Mycobacterium tuberculosis. According to the World Health Organization
(WHO) Global Tuberculosis Report 2012, tuberculosis causes over 1.4 million deaths
annually worldwide and a major cause of morbidity and mortality especially in the
developing countries in Asia and Africa (World Health Organization, 2012). The paucity
ofnewdrugsforthetreatmentoftuberculosisalongwiththerampantandunprecedented
rise of drug-resistant strains made it imperative to discover potential new drugs for
tuberculosis (Shah et al., 2007). The conventional process of drug discovery involves
screening of large molecular libraries of molecules for biological activities, and it is a
tedious, expensive and time-consuming process (DiMasi, Hansen & Grabowski, 2003).
Data mining approaches based on cheminformatics modeling has been extensively used
to prioritize molecules from large chemical datasets for specific biological activities. Such
in-silico prioritization of molecules has been suggested to accelerate drug discovery by
drasticallyreducingthetimeandcost-factorinconventionaldrugdiscoveryprocesses(Vert
&Jacob,2008;Melville,Burke&Hirst,2009;Schierz,2009;Vasanthanathanetal.,2009).
Cheminformatics and data mining approaches have been used to mine biological
activities from molecular data sets of ingredients in traditional Chinese medicines
(Li, Kong & Zhang, 2010; Zhang et al., 2013). The availability of large molecular databases
with systematically curated molecular data, sources and activities of ingredients of
traditional Chinese medicines offer a new opportunity to use advanced data-mining tools
tomineforpotentialactivities,especiallyforpathogenscausingneglectedtropicaldiseases
(Chen et al., 2006; Fang et al., 2008; Chen, 2011; Zhou, Xie & Yan, 2011). Previously we
used high-throughput bioassay data sets to create highly accurate data-mining classifiers
based on machine learning of molecular properties including antimicrobial activities for
a number of neglected tropical diseases including tuberculosis, and malaria (Periwal et al.,
2011;Periwal,Kishtapuram&Scaria,2012;Jamal,Periwal&Scaria,2013).
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molecular ingredients in traditional Chinese medicine and applied a host of previously
generatedcheminformaticsmodelsaimedatidentifyingpotentialhitswithantitubercular
activity against tuberculosis. We additionally employed methodologies for filtering out
potential molecules using a series of in-silico filters. Our analysis revealed a total of 19
hits for antitubercular activity from the dataset. In-depth literature survey suggests 4 of
these molecules are derived from plant products known to be used against tuberculosis,
suggesting that the computational approach can be immensely useful in identifying and
characterizing molecular activities. To the best of our knowledge, this is the first and
mostcomprehensivedata-miningandcheminformaticanalysisofpotentialantitubercular
agentsfromtraditionalChinesemedicineingredients.
MATERIALS AND METHODS
Data sets
Molecular data sets of ingredients of traditional Chinese medicines were retrieved from
traditional Chinese medicines Integrated Database (TCMID) (Ruichao et al., 2013).
TCMID constitutes one of the most comprehensive online resources for ingredients used
in TCM. The database hosts information on over 25,210 pure molecules retrieved from
literatureandotherdataresources.
Computational models for antitubercular activity
Thecomputationalpredictivemodelsusedinouranalysiswerebasedonthefollowingtwo
confirmatoryscreensconductedtoidentifynovelinhibitorsofMycobacterium tuberculosis
H37Rv, previously published by our group (Periwal et al., 2011; Periwal, Kishtapuram &
Scaria, 2012). The computational models used are available online at http://vinodscaria.
rnabiology.org/2C4C/models.
Briefly these models were based on two bioassays deposited in PubChem and carrying
IDs AID 1332 and AID 449762. Both the assays were based on microdilution Alamar
Blue assays. The former used 7H12 broth while the latter used 7H9 media. A total of
1,120 and 327,669 compounds were screened in the respective assays. The models were
generated using a machine learning approach as described in Periwal et al. (2011) and
Periwal, Kishtapuram & Scaria (2012). The AID 1332 assay model was generated based on
the Random forest classification algorithm and was evaluated using a variety of statistical
measures which include accuracy, Balanced Classification Rate (BCR) and Area under
Curve(AUC).BalancedClassificationRateisanaverageofsensitivityandspecificitywhich
introduces a balance in the classification rate. The model had an accuracy of 82.57%, BCR
value of 82.2% and AUC value of 0.87. The AID 449762 assay model was generated based
on SMO (Sequential Minimization Optimization) algorithm and was found to be 80.52%
accurate,withBCRvalueof66.30%andAUCas0.75.
In addition, we created an additional model to predict the molecules active against
non-replicating drug tolerant Mycobacterium tuberculosis. The assay was deposited in
PubChem with identifier AID 488890. A total of 3,24,437 compounds were screened for
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describedinthepreviouspapers(Periwaletal.,2011;Periwal,Kishtapuram&Scaria,2012;
Jamal, Periwal & Scaria, 2013; Jamal, Periwal & Scaria, 2012) and had an accuracy of 76%,
BCRvalue85.2%andAUC0.66.
Molecular descriptors
MoleculardescriptorsforeachofthemoleculeswerecomputedusingPowerMV(Liu,Feng
& Young, 2005), popular cheminformatics software widely used to compute molecular
descriptors.Atotalof179moleculardescriptorswerecomputedforeachmolecule.Outof
the total 179 molecular descriptors, a few descriptors were pruned using bespoke scripts
written in Perl depending on whether they were used in creating the respective models.
We pruned a total of 29 and 25 descriptors corresponding to AID 1332 and AID 449762
respectively,while25wereprunedfortheAID488890model.
Formats and format conversion
The molecules were downloaded in mol2 format and converted to SDF (Structural Data
Format) format using Openbabel (O’Boyle et al., 2011). The molecular descriptors were
converted to ARFF format compatible with Machine learning toolkit Weka (Bouckaert et
al., 2010). We used custom scripts written in Perl for the format conversions. A complete
listofscriptsisalsoavailableatCrowdComputingforCheminformatics(2C4C)repository
atURL:http://vinodscaria.rnabiology.org/2C4C/models.
SMARTS filters
TheSMARTSfilterisemployedtoremovethemoleculeswithfragmentsleadingtotoxicity
or unwanted reactivity. We used a set of SMARTS filters for the consensus candidate
anti-tubercular molecules. The online server SMARTSfilter (http://pasilla.health.unm.
edu/tomcat/biocomp/smartsfilter)webapplicationwasusedforallcomparisons.Theweb
application was used to filter out molecules, which match to any of the five undesirable
SMARTScatalogs.
Mycobacterium tuberculosis permeability prediction
The small molecules could not be effective unless they are able to penetrate the cell wall.
MycPermCheck(Mergetetal.,2013)acomputationaltooltopredictpermeabilityofsmall
moleculesacrossMycobacterium tuberculosis,wasemployedtofilterthesubsetofpotential
activemolecules.
Data mining
We used Weka, a popular and freely available Data Mining Software toolkit. Predictions
were performed for the dataset across the two models corresponding to assays AID
1332 and AID 449762 independently. Further, molecules predicted active in both the
datasets were collated and analyzed for additional properties including activity against
non-replicating drug tolerant Mycobacterium tuberculosis and potential to permeate the
Mycobacterium tuberculosiscellwall.Additionalfilterswhichdiscountmoleculeswithtoxic
Jamal et al. (2014), PeerJ, DOI 10.7717/peerj.476 4/17Figure 1 Summary of the data-mining and prioritization approach involving prediction of actives,
consensusbuildingandfilteringforpermeabilityandundesirablesubstructures.
fingerprints were removed using SMARTS filters. The summary of the entire workflow of
prioritizationisdepictedasaSchema(Fig.1).
RESULTS
Summary of datasets and molecules
A total of 25,210 ingredients were downloaded from Traditional Chinese Medicines
Integrated Database (TCMID). We could retrieve molecular information for only 12,018
of the ingredients in the form of SMILE notations and the rest were not considered
for further analysis. The molecules considered along with their SMILES are detailed
in Table S1. A total of 179 descriptors were calculated using PowerMV as described
above. The descriptors were further pruned for each of the models as described in the
Materials and Methods section using custom scripts in Perl. This corresponds to 150 and
154descriptorsrespectivelyformodelsAID1332andAID449762and154forAID488890.
The models, descriptors and scripts for formatting the files are available at the Crowd
Computing for Cheminformatics Model Repository (http://vinodscaria.rnabiology.org/
2C4C/models).
Prediction of potential anti-tubercular hits
The 12,018 molecules obtained from TCMID were analyzed for the antitubercular
activity using the computational predictive models as described above. The AID 1332
and AID 449762 models predicted 2,363 compounds and 5,864 compounds respectively
as potentially active anti-tubercular. Of these molecules, a total of 1,472 molecules were
predicted potential actives by both the models based on molecular descriptors and were
consideredforfurtheranalysis(TableS2).
Briefly we used a popular approach for filtering molecules with undesirable properties.
These included briefly using SMARTS filters. Molecules which passed the filtering
step were further evaluated for their effect against drug-tolerant and slow growing
Mycobacterium. Molecules were further evaluated for their potential permeability with
respecttotheMycobacterialcellwall.
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SMARTS filter for filtering undesirable structures
We used a set of five SMARTS filters to remove the molecules matching to any of these
filters. Such substructure based filtering approach has been extensively used to prioritize
molecules by filtering unwanted or potential false positives in cheminformatics screens
(Singla et al., 2013). The SMARTS filters included 5 independent approaches namely
Glaxo, PAINS, Oprea, Blake and ALARM-NMR used in tandem. Pan Assay Interference
Compounds (PAINS) describes a set of substructures known to be promiscuous and have
issues in high throughput assays (Baell & Holloway, 2010), while the Glaxo filter describes
unsuitable hits or unsuitable natural products (Hann et al., 2009). ALARM NMR assay
to detect reactive molecules by nuclear magnetic resonance (ALARM-NMR) set filters
for molecules which are reactive false positives in high-throughput assays by oxidizing or
alkylatingaproteintarget(Huthetal.,2005).TheGlaxo,OpreaandBlakefilterswerebased
on specific fitness properties. The Glaxo method involves classification of the molecules
into different chemical categories based on the presence of acids, bases, electrophiles and
nucleophiles in the molecule. Prior to the categorization the molecules are filtered for
non-druglikepropertiesandtoremoveinappropriatefunctionalgroups(unsuitableleads
andunsuitablenaturalproducts)(Hannetal.,2009).
Out of a total of 1,472 molecules, 160 molecules passed all the filters. A total of 63.1%
(929) molecules failed the ALARM NMR filter, while 49.9% (734) failed to pass Oprea
filter. Similarly 49% (722) failed to pass the PAINS filter. The detailed schema showing the
number of molecules failed by each filter is depicted in Fig. 2. A similar comparison of the
complete set of 12,018 TCMID compounds revealed that only 1,539 compounds passed
all the filters. We observed that most of the molecules did not pass through ALARM NMR
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48.3%moleculescouldnotpassthroughthePAINSfilter.
Molecules potentially active against non-replicating drug tolerant
Mycobacterium tuberculosis
A total of 160 compounds filtered through SMARTSfilter were tested using a compu-
tational predictive model for potential activity against non-replicative Mycobacterium
tuberculosis. The model predicted 19 compounds as active to act as potential inhibitors of
non-replicating drug tolerant Mycobacterium tuberculosis. The detailed description about
19 compounds is given in Table 1. The table also shows the permeability probability of the
moleculestopassthroughMtbcellwall.
Pharmacophore search in 19 molecules found to be potentially
active against non-replicating drug tolerant Mycobacterium
tuberculosis
Since pharmacophore represents the features which play a key role in the recognition
of ligand by the target molecule, we generated the pharmacophore features for the 19
molecules identified to be active against non-replicating drug tolerant Mycobacterium
tuberculosis using PharmaGist software (Schneidman-Duhovny et al., 2008). PharmaGist
computes the pharmacophore model by doing multiple flexible alignments of the input
molecules.Wehavereportedthethreehighest-scoringpharmacophoreswhichcanbeused
forthediscoveryofnoveldrugentities(Fig.3).
Mycobacterium tuberculosis permeability prediction
WeemployedMycPermChecktopredictmolecularpermeabilitytoMycobacterialcellwall
to estimate the potential permeability of the prioritized molecules. All the 160 molecules
which passed the five SMARTSfilters were further evaluated for their ability to penetrate
Mtb cell wall. Analysis revealed 9 molecules with highest probability (>0.98) to permeate
theMycobacteriumcellwallbarrier(TableS3).
Literature search suggests evidence of the sources and molecules
used with antitubercular properties
We further searched for the role of the plant sources of the molecules with regard to their
use or known information on antibacterial or antitubercular activities. We found several
molecules in herbs to have antitubercular effects. These are Petasites japonicus (John,
1977), Piper trichostachyon (Wagner & Wolff, 1977), Solanum torvum (Silva et al., 2011),
Fritillaria przewalskii (Chang & Paul, 2001), Hernandia sonora (Udino et al., 1999) and
Phyllanthus urinari (Nair & Abraham, 2008). In addition, many of the herbs have been
shownto have hepatoprotective activities,which includeAnnona reticulata(Thattakudian
Sheik Uduman, Sundarapandian & Muthumanikkam, 2011; Mohamed Saleem et al., 2008),
Annona squamosa (Thattakudian Sheik Uduman, Sundarapandian & Muthumanikkam,
2011; Mohamed Saleem et al., 2008), and Camellia sinensis (Issabeagloo & Taghizadieh,
2012). This offers a new opportunity for new drug development considering that most
of the established first-line drugs used in the treatment of tuberculosis are hepatotoxic
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Compound
no.
Compoundstructure Name Englishname Latinname Permeability
probability
Sourceswith
antitubercular
activities
1. F lemichapparin b Climbing Jewelvine Derris scandens 0.993
2. Murrayafoline A Taiwan Common
Jasminorange,
Indian Common
Jasminorange,
Euchretaleaf
Common
Jasminorange,
Narrowfruit
Glycosmis Root
Murraya crenulata,
Murraya koenigii,
Murraya euchres-
tifolia, Glycosmis
stenocarpa
0.98
3. 2-hexenyl benzoate Common Tea,
Szechwan
Tangshen
Camellia sinensis,
Codonopsis tangshen
0.855
4. Anonaine Hindu Lotus
Large Rhizome,
Bullocksheart
Custardapple,
Custard Apple,
Chinaberry-tree
Flower, Uncinate
Tailgrape
Nelumbo nucifera,
Annona reticulata,
Annona squamosa,
Melia azedarach,
Artabotrys uncinatus,
0.52
5. Orchinol Frog Orchid,
European
Gymnadenia,
Liriop Equivalent
plant: Liriope
spicata var
prolifera
Coeloglossum viride
[Syn. Coeloglossum
viride var. bractea-
tum], Gymnadenia
albida, Ophiopogon
japonicus
0.407
6. 1-phenyl-1-
pentanone
Chuanxiong rhizome,
Szechuan lovage
root, Chuanxiong
(Wallich Ligusticum)
Equivalent plant:
Cnidium officinale
Radix chuanxiong;
G Rhizoma Chuanx-
iong, Ligusticum
chuanxiong
0.338
7. Brassilexin India Mustard Brassica juncea 0.295
(continued on next page)
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Compound
no.
Compoundstructure Name Englishname Latinname Permeability
probability
Sourceswith
antitubercular
activities
8. Bisacumol Zedoary Turmeric
Equivalent plant:
Curcuma
kwangsiensis,
Common Turmeric
Equivalent plant:
Curcuma aromatica
Curcuma zedoaria,
Curcuma longa
0.104
9. Totarol Longleaf Podocarpus
Leaf Equivalent
plant: Podocarpus
macrophyllus
var maki,
Water Nightshade
Podocarpus
macrophyllus,
Solanum torvum
0.037 Solanum
torvum
10. Cyclostachine a Hairspike Pepper Piper trichostachyon 0.029 Piper tri-
chostachyon
11. Isolobinine Indian Tobacco,
Chinese Lobelia
Lobelia inflata,
Lobelia chinensis
0.018
12. Urinatetralin Common
Leafflower
Phyllanthus
urinaria
0.012 Phyllanthus
urinaria (Nair
& Abraham,
2008)
13. 2-methoxy-1h- pyrrole 0.004
(continued on next page)
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Compound
no.
Compoundstructure Name Englishname Latinname Permeability
probability
Sourceswith
antitubercular
activities
14. Gmelofuran Medicinal Breynia
Leaf
Breynia officinalis 0.00
15. Petasalbin
methyl ether
Japanese Butterbur Petasites japonicus 0.00 Petasites
japonicus
16. Verruculotoxin 0.00
17. Hinokiol Yellowish Rabdosia Isodon flavidus 0.00
18. Thymine Przewalsk Fritillary,
Anhui Fritillary,
Ussuri Fritillary
Fritillaria przewalskii,
Fritillaria anhuiensis,
Fritillaria ussuriensis
0.00 Fritillaria
przewalskii
(Chang & Paul,
2001)
19. n-methylcorydaldine Fendler’s Meadowrue,
Bracteate Poppy,
Asiatic Moonseed
Root, Lotusleaftung
Thalictrum fendleri,
Papaver bracteatum,
Menispermum
dauricum,
Hernandia
sonora
0.00 Hernandia
sonora
(Yew & Leung, 2006; Liu et al., 2008). We also found these molecules, Hinokiol (Chen et
al., 2009), Totarol (Jaiswal et al., 2007), Murrayafoline A (Choi et al., 2006) and 2-hexenyl
benzoate (Yantao, Zeng & Zhang) have been known to show antitubercular effects. The 9
molecules, which were identified by MycPermCheck, are able to penetrate the cell wall
of Mycobacterium tuberculosis (Table S3). We tried to find if any of these molecules
have been observed to show antitubercular or antimicrobial activity and we found 6
molecules that include Thalfinine (Zhou, Xie & Yan, 2011), Azulene (Kurti & Uldrich,
1958), Erypoegin E (Sato et al., 2006), Pongapinone A (Rani et al., 2013), Achilleol C
(Iinumaetal.,1996)andMurrayafolineA(Choietal.,2006).
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theinputmolecules. The pharmacophores are coloured in magenta.
DISCUSSION AND CONCLUSIONS
Traditional Chinese Medicine (TCM) has been a major alternative medicine practice,
widely followed in many parts of China and Southeast Asia (Ooi, 1993). Enormous
efforts in the recent years have been invested in the systematic identification and
characterization of the molecular activities of the ingredients and scientific validation of
their effects (Li &Brown, 2009;Wen etal., 2011). The availability of well curateddatabases
of ingredients of traditional Chinese medicines has opened up new avenues for molecular
screening as well as in-silico studies, including target-based docking (Chen et al., 2006;
Fangetal.,2008;Chen,2011;Zhou,Xie&Yan,2011).IndepthscreensofChinesemedicine
derived compounds have been performed for a variety of pathophysiologies, including
cancer (Hu et al., 2013), inflammatory diseases (Han & Guo, 2012; Su & Hsieh, 2011),
cardiovascular diseases (Wang et al., 2013) and infections (Jiang, Deng & Wu, 2013), just
to name a few. These databases are being extensively used for therapeutic development
(Chengetal.,2010).
Our group has used a machine learning based approach on publicly available
high-throughput screen datasets to create highly accurate models for predicting specific
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Kishtapuram & Scaria, 2012) and malaria (Jamal, Periwal & Scaria, 2013). Such accurate
in-silico models offer a new opportunity to prioritize large molecular databases in silico,
significantly reducing the failures, cost and effort. The availability of a well-curated
database of molecular ingredients of traditional Chinese medicines offer a new oppor-
tunitytominepotentialactiveantitubercularagentsandprioritizethemforscreeningand
in-depthfunctionalassays.
Inthepresentstudy,wehaveusedtwocomputationalmodelsbasedonhighthroughput
assays on Mycobacterium tuberculosis. In addition to the predictive models, we used a
filter based approach to filter out potential false positives/toxic molecules. Our analysis
revealed a total of 1,472 molecules predicted active by both the models, of which 160
molecules passed all the five filters. These molecules were further evaluated for their
permeability to mycobacterial cell wall and potential additional activity on drug-tolerant
and non-replicating Mycobacterium tuberculosis. We also further show evidence from
literature that these molecules or their sources have been used in the treatment of
therapeutics. This study is not without caveats; the primary one being that the consensus
approach used in the present study could be over-stringent so as to miss out on potential
antitubercular hits from the screening approach. The second, being that the findings
would require re-screening and in-depth functional analysis. Nevertheless we show from
independent evidence that molecular ingredients or sources of the prioritized molecules
have been extensively used as antibacterial or specifically in the treatment of tuberculosis.
In the present study we show a proof-of-concept that data-mining approaches using
accurate cheminformatics models could possibly be used to mine large datasets and
prioritizemoleculesforantitubercularscreening.
Our analysis suggests that molecular ingredients of traditional Chinese medicines
offer an attractive starting point to mine for potential antitubercular agents. Chinese
medicines alone (Lu et al., 2013) or in combination (Li et al., 1984) with western
medicine have been explored for the treatment of tuberculosis. Potential use of Chinese
medicines in combination with the standard antitubercular drugs could be an attractive
alternative that could be explored in much detail. There is ample evidence in published
literature that some of the ingredients of the short-listed antitubercular molecules have
additional hepatoprotective action, which could be effectively used in the background
of hepatotoxicity induced by the first line of drugs. We also suggest that 19 of the
prioritized molecules have additional activity against drug-tolerant and non-replicating
Mycobacterium tuberculosis suggesting that they could be potentially developed into leads
for Multidrug resistant and latent tuberculosis. We hope that this report would accelerate
in-depth analysis and discovery of anti-tubercular agents from molecular ingredients of
traditionalChinesemedicines.
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